GoodRx Holdings, Inc. Class A (GDRX)

Over the past six months, GoodRx's stock price has experienced a significant decline of approximately 55%. In Q1 2026, GoodRx reported revenue of $194 million, surpassing forecasts but representing a 4.4% year-over-year decrease. The company raised its full-year 2026 revenue guidance due to stronger performance in its Pharma Direct segment. Pharma Direct revenue increased significantly, while prescription transactions revenue decreased. Monthly active consumers remained flat. GoodRx expanded its offerings to include access to GLP-1 drugs and announced collaborations with Viatris and Pfizer. Director Ian T. Clark resigned, and Chief Accounting Officer Romin Nabiey also departed.

GoodRx's revenue growth expectations for 2024 have been supported by increased utilization from seasonal factors, indicating that demand for its products and services may experience fluctuations throughout the year influenced by seasonal trends in healthcare needs or consumer behavior.

GoodRx Holdings, Inc. is an American digital healthcare platform focused on lowering healthcare costs in the United States, operating within the Medical sector. It connects various stakeholders to facilitate medication savings through its prescription marketplace, telehealth services (GoodRx Care), GoodRx Gold membership program, pharma manufacturer solutions, and GoodRx Shop.

GoodRx Holdings, Inc. primarily focuses its operations on the U.S. market, comparing prescription drug prices at more than 75,000 pharmacies nationwide. The company is headquartered in Santa Monica, California.

GoodRx maintains strong brand recognition and a positive provider Net Promoter Score (NPS). The company's efforts to expand access to affordable medications and its focus on high-demand areas like GLP-1 drugs contribute positively to its reputation. There were no specific negative events directly impacting GoodRx's brand reputation reported in the past year, beyond the general stock performance and governance changes.

GoodRx Holdings, Inc. has a diversified ownership structure, including institutional investors, its founders, and the public. Retail investors collectively own the largest share, holding 49% of the company. Major institutional owners include Francisco Partners Management, LP, Vanguard Group Inc, and Silver Lake Group, L.L.C. Key individual owners and insiders include Doug Hirsch, Trevor Bezdek, and Abdiel Capital Management LLC.